Agilent Technologies, Inc. (LON:0HAV)
London · Delayed Price · Currency is GBP · Price in USD | Market Cap | 26.38B |
| Revenue (ttm) | 5.13B |
| Net Income (ttm) | 922.58M |
| Shares Out | n/a |
| EPS (ttm) | 3.24 |
| PE Ratio | 28.60 |
| Forward PE | 21.26 |
| Dividend | 0.75 (0.61%) |
| Ex-Dividend Date | Jul 1, 2025 |
| Volume | 1,094 |
| Average Volume | 216 |
| Open | 118.80 |
| Previous Close | 118.30 |
| Day's Range | 118.38 - 124.04 |
| 52-Week Range | 96.93 - 153.50 |
| Beta | 1.22 |
| RSI | 61.56 |
| Earnings Date | Aug 27, 2025 |
About Agilent Technologies
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry inst... [Read more]
Financial Performance
In 2024, Agilent Technologies's revenue was $6.51 billion, a decrease of -4.73% compared to the previous year's $6.83 billion. Earnings were $1.29 billion, an increase of 3.95%.
Financial numbers in USD Financial StatementsNews
Agilent to Participate in 2025 Wells Fargo Healthcare Conference
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that President and CEO Padraig McDonnell will participate in a fireside chat at this year's Wells Fargo Health...
Agilent, Bristol Myers win FDA nod for cancer diagnostic test
Agilent MMR IHC Panel pharmDx (Dako Omnis) Receives FDA Approval as a Companion Diagnostic Test for Colorectal Cancer
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that its MMR IHC Panel pharmDx (Dako Omnis) has received FDA approval as a companion diagnostic (CDx) test for...
VB AI Impact Series: Can you really govern multi-agent AI?
SAP'S Yaad Oren and Agilent's Raj Jampa discuss how to deploy agentic AI while staying inside cost, latency, and compliance guardrails.
Shane Snyder to Lead New Agilent Center of Excellence at Georgia Tech Focused on Water and the Environment
SANTA CLARA, Calif. & ATLANTA--(BUSINESS WIRE)--Agilent Technologies Inc. and Georgia Tech today announced the establishment of an Agilent Center of Excellence (CoE) for Environmental Health and Engin...
Agilent: A Lean, Focused Play In Life Sciences Tools Amid Tariff Turbulence
Agilent opens new biopharma centre in Hyd
Hyderabad: US-based analytical and clinical laboratory technologies player Agilent Technologies Inc has opened its new biopharma experience centre in .
Agilent Expands the Dako Omnis Family with Three New Models to Meet Evolving Pathology Lab Needs
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the introduction of its Dako Omnis family of instruments with three new models—Agilent Dako Omnis 110, 165, an...
Monthly Pay Dividends, From 83 Equities, 80 Funds, And 28 Ideal 'Safer' Dogs For August
Most MoPay equities and funds offer annual dividends from a $1K investment that exceed their share price, presenting affordable but volatile opportunities. Analyst estimates suggest the top ten MoPay ...
Agilent Tech looks to double investments in India, eyes high-teen growth, CEO says
U.S.-based laboratory equipment maker Agilent Technologies plans to double its investments in India to expand in one of its fastest-growing markets, a top executive said.
P/E Ratio Insights for Agilent Technologies
In the current session, Agilent Technologies Inc. (NYSE: A) is trading at $115.19, after a 1.01% drop. Over the past month, the stock fell by 1.07% , and in the past year, by 14.32% . With performanc...
Agilent to Announce Third-Quarter Fiscal Year 2025 Financial Results on Aug. 27
SANTA CLARA, Calif.--(BUSINESS WIRE)--Following an announcement earlier this week, Agilent Technologies Inc. (NYSE: A) confirms it will release financial results for the third quarter of fiscal year 2...
Agilent CFO Bob McMahon steps down
Agilent Announces CFO Transition
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that effective July 31, Senior Vice President and Chief Financial Officer Bob McMahon will step down from his ...
What's Driving the Market Sentiment Around Agilent Technologies?
Agilent Technologies's (NYSE: A) short percent of float has fallen 18.29% since its last report. The company recently reported that it has 3.35 million shares sold short , which is 1.34% of all regul...
Looking Into Agilent Technologies's Recent Short Interest
Agilent Technologies's (NYSE: A) short percent of float has fallen 5.17% since its last report. The company recently reported that it has 4.14 million shares sold short , which is 1.65% of all regula...
Agilent to Showcase New Products and Innovations at HPLC 2025
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that they will introduce their latest Hybrid Multisampler and highlight the new LC Single Quadrupole Mass Spec...
Agilent Technologies, Inc. (A) Jefferies Global Healthcare Conference - (Transcript)
Agilent Technology CEO Padraig McDonnell goes one-on-one with Jim Cramer
Agilent Technology President and CEO Padraig McDonnell joins 'Mad Money' host Jim Cramer to talk quarterly results, its China business, GLP-1 drugs, and more.
Agilent Braces For Potential US-EU Tariff Hike, Maintains Annual Outlook
Agilent Technologies Inc. (NYSE: A) reported second-quarter 2025 sales of $1.67 billion on Wednesday, almost in line with the consensus of $1.63 billion , representing growth of 6% reported and up 5....
Agilent signals 2.5%-3.5% core growth and outlines $130M profit boost through Ignite transformation for FY2025
Agilent Technologies, Inc. (A) Q2 2025 Earnings Conference Call Transcript
Agilent rises on boosted FY25 revenue projection, quarterly beats
Agilent Stock Gains as Earnings Surprise Despite Research Funding Cuts
Life sciences firm Agilent beats quarterly estimates on instrument demand
Agilent Technologies beat Wall Street estimates for second-quarter profit and revenue on Wednesday, helped by strong demand for its tools and equipment used in drug development, sending its shares up ...